[Anti remodeling therapy: new strategies and future perspective in post-ischemic heart failure. Part II]

Area of Science:

• Cardiovascular Medicine
• Regenerative Medicine
• Molecular Biology

Background:

• Increased survival post-myocardial infarction (MI) leads to a higher incidence of chronic heart failure.
• Incomplete understanding of cardiac tissue's response to ischemic injury hinders effective treatment.
• Complex interactions involving various cells and mediators regulate post-MI cardiac remodeling.

Purpose of the Study:

• To review current knowledge on post-infarct cardiac remodeling.
• To identify and evaluate emerging therapeutic targets for chronic heart failure.
• To focus on micro-RNA, post-translational modifications, and microsphere-based therapies.

Main Methods:

• Literature review of recent findings on post-MI remodeling.
• Evaluation of therapeutic strategies including gene therapy and stem cells.
• Analysis of micro-RNA, post-translational modifications, and microsphere-based therapies.

Main Results:

• Advances in understanding cellular and molecular mechanisms of cardiac repair.
• Identification of novel therapeutic targets beyond traditional approaches.
• Emerging potential of micro-RNA and microsphere-based therapies in preclinical studies.

Conclusions:

• Targeting specific molecular pathways offers new hope for treating heart failure post-MI.
• Micro-RNA and microsphere-based therapies represent promising avenues for future clinical translation.
• Continued research into cardiac remodeling mechanisms is essential for developing effective interventions.